Since we know the protein folds with other organisms DNA it is a must to treat for all organisms that are in contact to get well.
Look for new IDSA Parkinsons and ALS guidelines saying they cannot have antibiotics for as long as it takes to get well to protect their profits.
But if you have acne its ok.....
This is why Lyme patients cannot get help...They tried to cover it up any way they could---and preventing us from getting treatment was their best option...
-------------------- Suspected Lyme 07 Test neg One band migrating in IgG region unable to identify.Igenex Jan.09IFA titer 1:40 IND IgM neg pos 31 +++ 34 IND 39 IND 41 IND 83-93 + DX:Neuroborreliosis Posts: 5850 | From Kentucky | Registered: Dec 2008
| IP: Logged |
quote:Originally posted by Pinelady: But if you have acne its ok.....
apparently is also ok to feed cattle 70% of the abx consumed in the US.
btw people with acne should be allowed to take abx if it helps them. when i was in my 20's i took bactrim and it got rid of any acne i had. greatly improved my quality of life.
-------------------- sick since 9-09 igg, 18,23,41 reactive igm, 41 reactive Posts: 436 | From Kansas City | Registered: Jan 2010
| IP: Logged |
posted
I'm on the verge of an ALS diagnosis. Three years ago I was OK but said something was changing within me to the swedish doctors. But in Sweden chronic lyme does not exist. So now I'm finding myself with ALS instead, feels very bad if I may say so
-------------------- My blog about my condition - http://borreliawenttofar.wordpress.com - Diagnosed with cellular activity for Borrelia, Ehrlichia, Chlamydia Pneu. Also have the herpes simplex virus. Posts: 52 | From Sweden | Registered: Feb 2011
| IP: Logged |
posted
They keep talking about familial ALS characteristics, but these are only a fraction of ALS cases. So does this article also only apply to familial ALS?
Posts: 8430 | From Not available | Registered: Oct 2000
| IP: Logged |
Pinelady
Frequent Contributor (5K+ posts)
Member # 18524
posted
I think Sweden understands a lot more than they let on...
Out of ten researcher proposals which received funding from AFA insurance company, three are from the Medical Faculty at Lund University. ----------- Danstem > About DanStem About the Danish Stem Cell Center
The Danish Stem Cell Center (DanStem) is an new research center being established at the Faculty of Health Sciences, University of Copenhagen.
...The major goal of the Center is to enhance and fully integrate basic experimental and strategic translational research into stem cells focusing on two devastating diseases: diabetes and cancer. This venture will provide a solid platform for the development of interactive research efforts.
The center plans to open in the summer of 2011. When fully developed, the center will have approx. 100 researchers working in teams and guided by a group of internationally recognized principal investigators. Organisation
DanStem will be one center organised into two sections; one conducting basic research, the other conducting translational strategic research. This will create a unique environment for the exchange of ideas and data, with the sections able to share cutting-edge materials and equipment and make full use of the possibilities for synergy between basic and strategic translational research.
BasicStem: The Novo Nordisk Foundation Section for Basic Stem Cell Biology (BasicStem) will conduct basic research on the biology of pluripotent stem cells, how insulin-producing beta cells form during embryogenesis, the development of insulin-producing beta cells from stem cells and the development of cancer and the role of stem cells and cancer stem cells in this process. (Read more on Research)
Principal investigators will be Henrik Semb, Ole W. Petersen, Kristian Helin and Bo Porse (see profiles of the Researchers), with more to be recruited.
BasicStem is supported by a grant of 47 mil. euro from The Novo Nordisk Foundation.
TransStem: The Section for Strategic Translational Stem Cell Research and Therapy (TransStem) will conduct strategic translational research, with the goal of moving the ideas and results from BasicStem (and other relevant research on stem cell based therapies for cancer and diabetes) towards early clinical application (more on Research).
TransStem researchers at present are Henrik Semb, Ole W. Petersen, Kristian Helin and Bo Porse, and they will collaborate with the University hospital, Rigshospitalet; Uppsala University; and Novo Nordisk A/S.
TransStem is supported by a grant of 8,7 mil. euro from the Danish Council of Strategic Research. Location and facilities
DanStem will be located at the Faculty of Health Sciences at the University of Copenhagen. The Faculty is in the centre of a developing science city (Science City North), which will integrate the large campus area and the surrounding culturally vibrant areas into a coherent district, based on the concepts of science, health and interaction.
DanStem will be housed mainly in the Faculty's new laboratory building that is due to be functional in 2014. From 2011 to 2014, the Center will be based partly at the Faculty of Health Sciences and partly at the near-by Biotech Research and Innovation Centre (BRIC).
The Center will have access to a range of modern laboratory platforms and core facilities including: the Copenhagen Animal Research Unit, Core Facility for Integrated Microscopy, High Throughput Cell-based Screening Core Facility. Further platforms will be established including: a platform for ESCs and iPS cells, a cell separation platform and a viral vector platform. Stem cells and ethics at DanStem
The research activities undertaken by the Center will be performed in accordance with relevant national legislation. In addition, the Center will adhere to relevant international regulation, including but not limited to EU stem cell research guidelines.
Laboratory animal model research will be performed in the University's centralized facilities at the Department of Experimental Medicine, which is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). The head of department is Professor Jann Hau, who is internationally recognized as a leading expert in comparative medicine and laboratory animal welfare.
The Center will work with human ES cells derived from embryos left spare from IVF treatment that are obtained with freely given informed consent by donors.
The Center will establish an Ethical Review Committee. The committee will adopt Standard Operating Procedures and Guidelines for the research activities undertaken, review the research activities at regular intervals from a legal and ethical point of view and ensure appropriate reporting to authorities.
Professors G�ran Hermer�n and Nils-Eric Sahlin from Lund University will be appointed as external consultants specializing in the ethical aspects of research involving human translational stem cell research to assist the Ethical Review Committee in their work. Prof. Hermer�n is one of Europe's foremost experts on ethical issues related to stem cell research and was a member of the International Society for Stem Cell Research (ISSCR) Task Force on the Clinical Translation of Stem Cells. ------------------------ STEMTHERAPY scientists receive funding from AFA insurance company Professor Zaal Kokaia and Associate Professor David Bryder from Lund Stem Cell Center, members of the Stem Therapy program, received 6 and 5 million SEK, respectively for thei...r projects in the field of stem cell-based regenerative medicine.
* Read more
Henrik Semb will head up a new Stem Cell Center at Copenhagen University Professor Henrik Semb, presently director of the Stem Cell Center in Lund, will head up a new Stem Cell Center at Copenhagen University. The Danish Strategic Research Council and Novo Nordisk Foundation recently awarded a total of 415 million Danish kroner to a new research center for basic and translational stem cell research at Copenhagen University.
* Read more about The Danish Stem Cell Center (DanStem)
PhD student positions Within the StemTherapy program, financial support for six PhD student positions will be given in collaboration with the Research School in Stem Cell Biology. PhD projects with a relevance for StemTherapy and clinically oriented projects are prioritized and projects will start in 2011. ------------------------- http://www.rsdfoundation.org/en/research.html Incompetent IRBs and a corrupt FDA prevent research on RSD / CRPS -------------------- I find it absolutely flipping amazing---here the US will not even allow them to treat RDS/CRPS----while other countries are building giant facilities to do just that...
The losers of the US Medical societies barter with our lives to protect the few's profits.....NO wonder we rank 17th in the worlds science scores....
-------------------- Suspected Lyme 07 Test neg One band migrating in IgG region unable to identify.Igenex Jan.09IFA titer 1:40 IND IgM neg pos 31 +++ 34 IND 39 IND 41 IND 83-93 + DX:Neuroborreliosis Posts: 5850 | From Kentucky | Registered: Dec 2008
| IP: Logged |
The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:
The
Lyme Disease Network of New Jersey 907 Pebble Creek Court,
Pennington,
NJ08534USA http://www.lymenet.org/
UBBFriend: Email this page to someone!
![[Frown]](frown.gif)
Printer-friendly view of this topic